Shilpa Medicare announces acquisition of US based Pilnova Pharma

November 3, 2023
News
35 secs read

Source: CNBCTV18

Pharma major Shilpa Medicare has announced the acquisition of American pharma company Pilnova Pharma Inc. on Thursday (November 2). Upon completion of the acquisition process, Pilnova will become a wholly owned subsidiary of Shilpa Medicare.

As per the regulatory filing, Shilpa Medicare informed that it has bought a 100 percent stake in Pilnova Pharma at a price of one dollar per share. Pilnova Pharma, a US-registered pharma sector company, is involved in providing marketing and sales support.

Shilpa Medicare said that the move is aimed at establishing a front end presence in the US market. The company has also informed that this entire deal has been done in cash.

Shares of Shilpa Medicare were down nearly 1% on Thursday.

Pharmaways

Pharmaways Global Private Limited is a company established in 2022. Headed by a group of professionals with over 25 years of experience. A team of professionals who have excelled in their respective fields of Pharma, Legal & Information Technology. We have global exposure and hands-on experience of the global Pharma industry. We are in pursuit of bringing the global Pharma Industry on a platform where they can connect, collaborate and work towards mutual growth. We have taken a step into the future by innovating a technology that will help global Pharma players to empower, excel and accelerate in their business. A platform that has been developed exclusively for the Pharma fraternity. We are a New Delhi based company with overseas offices in America and the United Kingdom.